title: Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile.
abstract: Clostridium difficile infection (CDI) is responsible for most of the definable cases of antibiotic- and hospital-associated diarrhea worldwide and is a frequent cause of morbidity and mortality in older patients. C. difficile, a multidrug-resistant anaerobic pathogen, causes disease by producing toxins A and B, which are controlled by an accessory gene regulator (Agr) quorum signaling system. Some C. difficile strains encode two Agr loci in their genomes, designated agr1 and agr2 The agr1 locus is present in all of the C. difficile strains sequenced to date, whereas the agr2 locus is present in a few strains. The functional roles of agr1 and agr2 in C. difficile toxin regulation and pathogenesis were unknown until now. Using allelic exchange, we deleted components of both agr loci and examined the mutants for toxin production and virulence. The results showed that the agr1 mutant cannot produce toxins A and B; toxin production can be restored by complementation with wild-type agr1 Furthermore, the agr1 mutant is able to colonize but unable to cause disease in a murine CDI model. These findings have profound implications for CDI treatment because we have uncovered a promising therapeutic target for the development of nonantibiotic drugs to treat this life-threatening emerging pathogen by targeting the toxins directly responsible for disease.
  
  
  
  Within the last decade, the number of cases of C. difficile infections has been increasing exponentially in the United States, resulting in about 4.8 billion U.S. dollars in health care costs annually. As a multidrug-resistant, spore-forming, anaerobic pathogen, C. difficile overpopulates the colon after the gut microbiota has been altered by antibiotic therapy. With increasing resistance to antibiotic treatment of C. difficile infections, patients are experiencing higher costs of health care and a lower quality of life as treatment options decrease. During infection, C. difficile produces toxins A and B, which directly cause disease. As a result, the toxins have become promising nonantibiotic treatment targets. Here, we have identified a pathway responsible for activating the production of the toxins. This important finding opens up a unique therapeutic target for the development of a novel nonantibiotic therapy for C. difficile infections.
authors.affiliation: Department of Epidemiology, Human Genetics, and Environmental Sciences, Center For Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA Microbiology and Molecular Genetics Program, University of Texas Graduate School of Biomedical Sciences, Houston, Texas, USA Charles.darkoh@uth.tmc.edu.
authors.forename: Charles
authors.identifier: 0000-0003-0063-7856
authors.initials: C
authors.lastname: Darkoh
authors.affiliation: Department of Epidemiology, Human Genetics, and Environmental Sciences, Center For Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA.
authors.forename: Chioma
authors.initials: C
authors.lastname: Odo
authors.affiliation: Department of Epidemiology, Human Genetics, and Environmental Sciences, Center For Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA Microbiology and Molecular Genetics Program, University of Texas Graduate School of Biomedical Sciences, Houston, Texas, USA.
authors.forename: Herbert L
authors.initials: HL
authors.lastname: DuPont
mesh_terms: D000818:Animals; D001427:Bacterial Toxins / Q000096:biosynthesis*; D016360:Clostridioides difficile / Q000235:genetics / Q000254:growth & development* / Q000472:pathogenicity*; D003015:Clostridium Infections / Q000382:microbiology / Q000473:pathology; D004195:Disease Models, Animal; D017353:Gene Deletion; D005809:Genes, Regulator; D005816:Genetic Complementation Test; D056426:Genetic Loci; D051379:Mice; D014774:Virulence
chemical_list: D001427:Bacterial Toxins